MedTrace Logo

Post-radiation Hypothyroidism After IMRT for Nasopharyngeal Carcinoma

NCT02689609 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 149

Last updated 2019-10-02

No results posted yet for this study

Summary

The investigators evaluate if there are radiation dosimetric parameters for the prediction of biochemical and clinical hypothyroidism after intensity-modulated radiation therapy (IMRT) for non-metastatic nasopharyngeal carcinoma (NPC).

Conditions

Interventions

RADIATION

Intensity-modulated radiation therapy

All patients will receive intensity-modulated radiation therapy with or without chemotherapy as usual standard of care in our institution.

Sponsors & Collaborators

  • City University of Hong Kong

    collaborator OTHER

  • The University of Hong Kong

    lead OTHER

Principal Investigators

  • Victor HF Lee, MD · The University of Hong Kong

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2013-12-31
Completion
2016-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02689609 on ClinicalTrials.gov